Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117920722 | 11792072 | 2 | F | 20160722 | 20151201 | 20160729 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-66635BI | BOEHRINGER INGELHEIM | 0.00 | F | Y | 65.98000 | KG | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117920722 | 11792072 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | 22512 | 150 | MG | CAPSULE | BID | ||||||
| 117920722 | 11792072 | 2 | C | ASPIR-LOW | ASPIRIN | 1 | Oral | 81 MG | 0 | 81 | MG | QD | |||||||
| 117920722 | 11792072 | 3 | C | LOVASTATIN. | LOVASTATIN | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 117920722 | 11792072 | 4 | C | LEVOTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 88 MCG | 0 | 88 | UG | TABLET | QD | ||||||
| 117920722 | 11792072 | 5 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | FORMULATION: DELAYED RELEASE CAPSULE | 0 | 20 | MG | ||||||||
| 117920722 | 11792072 | 6 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG | 0 | 20 | MG | QD | |||||||
| 117920722 | 11792072 | 7 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | Oral | 0 | 25 | MG | TABLET | ||||||||
| 117920722 | 11792072 | 8 | C | ROPINIROLE. | ROPINIROLE | 1 | Oral | 0.25 MG | 0 | .25 | MG | TABLET | QD | ||||||
| 117920722 | 11792072 | 9 | C | METAMUCIL ORANGE SMOOTH TEXTURE | 2 | Oral | FORMULATION: POWDER FOR RECONSTITUTION, DOSE: 3.4G/12 G | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117920722 | 11792072 | 1 | Atrial fibrillation |
| 117920722 | 11792072 | 2 | Product used for unknown indication |
| 117920722 | 11792072 | 3 | Product used for unknown indication |
| 117920722 | 11792072 | 4 | Product used for unknown indication |
| 117920722 | 11792072 | 5 | Product used for unknown indication |
| 117920722 | 11792072 | 7 | Dizziness |
| 117920722 | 11792072 | 8 | Restless legs syndrome |
| 117920722 | 11792072 | 9 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117920722 | 11792072 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117920722 | 11792072 | Gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |